2010
DOI: 10.2174/138945010790711914
|View full text |Cite
|
Sign up to set email alerts
|

Computational Methods for De novo Protein Design and its Applications to the Human Immunodeficiency Virus 1, Purine Nucleoside Phosphorylase, Ubiquitin Specific Protease 7, and Histone Demethylases

Abstract: This paper provides an overview of computational de novo protein design methods, highlighting recent advances and successes. Four protein systems are described that are important targets for drug design: human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases. Target areas for drug design for each protein are described, along with known inhibitors, focusing on peptidic inhibitors, but also describing some smallmolecule inhibitors. Computational d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 206 publications
(210 reference statements)
0
12
0
Order By: Relevance
“…Knowledge‐based potential functions are used in many different types of computational protein studies, including protein structure prediction,1–5 protein design,6–9 docking applications,10–13 and protein folding mechanism studies 14–17. Many atomistic potential functions18–20 and coarse‐grained potential functions21–24 have been developed.…”
Section: Introductionmentioning
confidence: 99%
“…Knowledge‐based potential functions are used in many different types of computational protein studies, including protein structure prediction,1–5 protein design,6–9 docking applications,10–13 and protein folding mechanism studies 14–17. Many atomistic potential functions18–20 and coarse‐grained potential functions21–24 have been developed.…”
Section: Introductionmentioning
confidence: 99%
“…Computational Protein Design (CPD) enables systematic, high throughput protein, and ligand mutagenesis and has been the focus of several laboratories in recent years, resulting in significant developments in methodology and applications 1–13. CPD has been used to modify specificity,14–17 to improve protein‐ligand binding,18–24 to increase stability,25, 26 to stabilize novel or alternative protein folds,27, 28 to perform fold recognition and homology searching,5, 11 to design new proteins,29, 30 and enzyme active sites,31, 32 to optimize ligand entrance and escape pathways,33 to create water‐soluble variants of membrane proteins,34 to redesign protein‐protein interfaces,20, 22, 35, 36 and to rewire biological networks 37…”
Section: Introductionmentioning
confidence: 99%
“…In some cases, particularly with the linear α-helices, this may be poor assumption. In fact, recent work suggests that optimizing a sequence to stabilize a conformation is a viable option to improving potency [36][37][38][39][40][41][42][43].…”
Section: Methodsmentioning
confidence: 99%